Desogestrel: Clinical Trials

5 trials of Desogestrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility
Phase 1CompletedMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany242025-11-242026-03-18
Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
Desogestrel 0.075 MG - Bioequivalence
Phase 1CompletedLaboratorios Andromaco S.A.302020-01-112020-06-09
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability
Phase 1CompletedBayer682017-11-292020-04-15
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
Desogestrel/ethinyl estradiol and ethinyl estradiol, 28-day drospirenone oral contraceptive, 28-day levonorgestrel oral contraceptive - Follicle Development, Ovarian Follicle
Phase 1CompletedTeva Branded Pharmaceutical Products R&D, Inc.2062011-01-312021-12-08
Antagonist/Letrozole in Poor Responders
letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation
Phase 1 / Phase 2CompletedYazd Research & Clinical Center for Infertility1202008-06-012013-12-23

Conditions studied

Infertility (1)

Sponsors

Bayer (1)  ·  Laboratorios Andromaco S.A. (1)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)  ·  Yazd Research & Clinical Center for Infertility (1)

Countries

Chile (1)  ·  Germany (1)  ·  Iran (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2017 (1)